Ripley Named New Director of Mesothelioma Center at Baylor
September 12, 2018
Thoracic surgeon Dr. R. Taylor Ripley comes to the Mesothelioma Treatment Center at Baylor College of Medicine with the highest possible endorsement.
Dr. David Sugarbaker, the world’s most prominent mesothelioma specialist and former director of the prestigious Baylor Lung Institute, recruited Ripley.
It was like being anointed by the king.
Ripley spent the previous four years at the National Cancer Institute (NCI) in Bethesda, Maryland, where he built a sterling reputation for surgical, clinical and investigational research excellence.
“Dr. Sugarbaker wanted someone to help grow his program. He recruited me to do that. It is one of the greatest honors I’ve ever had,” Ripley told Asbestos.com. “Mesothelioma will be my No. 1 focus.”
Ripley, 41, becomes the director of a program that has grown into one of America’s leading mesothelioma specialty centers under Sugarbaker. The famed surgeon had been a pioneer in mesothelioma treatment advancements for almost three decades.
Sugarbaker died Aug. 29. He was 65.
Learning from Other Specialists
Expectations for Ripley are especially high — like joining the Super Bowl champions as a No. 1 pick in the NFL Draft.
“It comes with extreme responsibility to maintain the highest quality for all the patients and the entire field [of mesothelioma],” he said. “Expectations should be high.”
Ripley earned his degree from the Vanderbilt University Medical School. He trained in thoracic surgery at New York’s Memorial Sloan Kettering (MSK) Cancer Center, which has another highly regarded mesothelioma program.
At MSK, he worked closely with thoracic surgeon Dr. Valerie Rusch, a mesothelioma specialist who piqued his interest in this rare and aggressive cancer. His interest continues to grow.
At the NCI, he worked with the multidisciplinary thoracic team that included thoracic oncologist Dr. Raffit Hassan, a leader in mesothelioma research.
“It takes a very patient-specific, family-centric approach to caring for a person with mesothelioma,” Ripley said. “I was drawn to that. I enjoy dealing with mesothelioma patients because I get to know them well. The harder the management of a disease becomes, the more time it takes, and the better I get to know them and their families.”
Focus on Long-Term Patient Care
Ripley believes his role with mesothelioma patients at Baylor will extend well beyond the surgery he performs and move toward a more personalized approach. He and his patients usually exchange cellphone numbers when they first meet. Ripley will be there for them every step of the way.
“I enjoy seeing patients. I don’t want a practice doing routine, short operations where patients come and go,” he said. “I enjoy seeing how they do, seeing them do well, and seeing if I can help coach them to live the very best they can. I’m always available.”
He believes in thoroughly educating each patient about the path they have taken. Instead of one presurgery consultation, he prefers two with each patient, making sure all questions and concerns are answered.
Ripley wants family involvement. He encourages dialogue. And he spends considerable time with each patient outside the operating room.
“The more knowledgeable the patient is going into the process, the more they become an ally. The more prepared pre-operatively, the more likely they are to overcome the operation, the recovery, and the bumps in the road they will experience,” he said. “Taking care of these patients is a lifelong commitment.”
Expertise in the OR and the Lab
He credits Rusch and Dr. Steven A. Rosenberg, chief of surgery at the NCI, for teaching him the surgical technique and mental approach to this difficult disease.
“The most important thing I learned was that when taking on a problem, it needs to be addressed with extreme focus,” he said. “If there is problem that needs solved, it requires being very specific in the approach to finding a solution to achieve whatever the goal may be — whether that’s in the lab, the clinic or the OR.”
In addition to performing all types of mesothelioma surgery, Ripley has brought his laboratory research efforts from the NCI to Baylor.
He is heavily involved in cell biology and tumor metabolism, which is the reprograming of cells to make them more vulnerable to therapy.
It was one of the reasons he was recruited at Baylor, which wanted to add another dimension to its blossoming mesothelioma program.
His whole approach beyond the operating room was another.
“There are certain things we can do for patients with medical therapy, but there also are things we can coach in order to extend the quality — and potentially the length — of their lives,” he said. “I enjoy doing it all.”